Liabilities in USD of Regencell Bioscience Holdings Ltd from Q2 2020 to Q2 2025

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary: Regencell Bioscience Holdings Ltd quarterly Liabilities history and growth rate from Q2 2020 to Q2 2025.
Regencell Bioscience Holdings Ltd Liabilities for the quarter ending June 30, 2025 was $895K, a 308% increase year-over-year.

Liabilities, Quarterly (USD)

Liabilities, YoY Quarterly Growth (%)

Regencell Bioscience Holdings Ltd Quarterly Liabilities (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2025	$895K	+$676K	+308%	Jun 30, 2025	20-F	2025-10-31
Q2 2024	$220K	-$413K	-65.3%	Jun 30, 2024	20-F	2025-10-31
Q2 2023	$632K	-$306K	-32.6%	Jun 30, 2023	20-F	2024-10-25
Q2 2022	$938K	-$3.4M	-78.4%	Jun 30, 2022	20-F	2023-10-27
Q2 2021	$4.34M	+$1.17M	+37.1%	Jun 30, 2021	20-F	2022-10-31
Q2 2020	$3.16M			Jun 30, 2020	20-F	2021-10-29

* An asterisk sign (*) next to the value indicates that the value is likely invalid.